Literature DB >> 19507761

Pleomorphic adenoma: extracapsular dissection versus partial superficial parotidectomy with facial nerve dissection.

Robert L Witt1, Lidia Rejto.   

Abstract

BACKGROUND: To determine if Extracapsular Dissection (ECD) versus Partial Superficial Parotidectomy (PSP) differ in terms of tumor recurrence and transient and permanent facial nerve dysfunction. ECD does not dissect the facial nerve. PSP dissects the facial nerve and provides a 1-2 cm margin around the tumor.
METHODS: A 38-year Ovid Medline search (1970-2008) and an historical review with statistical analysis of published manuscripts were performed.
RESULTS: Tumor recurrence occurred in 36/1183 (3.0%) ECD cases and 1/340 (0.3%) PSP cases; (p < 0.05). Permanent facial nerve dysfunction occurred in 22/1202 (1.8%) ECD cases and 2/924 (0.2%) PSP cases; (p < 0.05). Transient facial nerve dysfunction occurred in 112/1036 (11.8%) ECD cases and 142/793 (17.9%) PSP cases; (p < 0.05%).
CONCLUSIONS: Historical review with statistical analysis of published series demonstrate a significantly higher rate of recurrent pleomorphic adenoma and permanent facial nerve dysfunction and a lower rate of transient facial nerve dysfunction with ECD compared to PSP.

Entities:  

Mesh:

Year:  2009        PMID: 19507761

Source DB:  PubMed          Journal:  Del Med J        ISSN: 0011-7781


  12 in total

Review 1.  Surgical options in benign parotid tumors: a proposal for classification.

Authors:  Miquel Quer; Vincent Vander Poorten; Robert P Takes; Carl E Silver; Carsten C Boedeker; Remco de Bree; Alessandra Rinaldo; Alvaro Sanabria; Ashok R Shaha; Albert Pujol; Peter Zbären; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-21       Impact factor: 2.503

2.  Safety of extracapsular dissection in benign superficial parotid lesions.

Authors:  F Riffat; A K Mahrous; M A Buchanan; B M Fish; P Jani
Journal:  J Maxillofac Oral Surg       Date:  2012-04-04

Review 3.  Review of surgical techniques and guide for decision making in the treatment of benign parotid tumors.

Authors:  Georgios Psychogios; Christopher Bohr; Jannis Constantinidis; Martin Canis; Vincent Vander Poorten; Jan Plzak; Andreas Knopf; Christian Betz; Orlando Guntinas-Lichius; Johannes Zenk
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-04       Impact factor: 2.503

4.  Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors.

Authors:  Pawel Sowa; Maciej Misiolek; Maciej Zielinski; Bogdan Mazur; Monika Adamczyk-Sowa
Journal:  Exp Biol Med (Maywood)       Date:  2018-05

5.  Pleomorphic adenoma of the parotid: extracapsular dissection compared with superficial parotidectomy--a 10-year retrospective cohort study.

Authors:  Maria Giulia Cristofaro; Eugenia Allegra; Amerigo Giudice; Walter Colangeli; Davide Caruso; Ida Barca; Mario Giudice
Journal:  ScientificWorldJournal       Date:  2014-10-21

6.  Parotid tumours: clinical and oncologic outcomes after microscope-assisted parotidectomy with intraoperative nerve monitoring.

Authors:  F Carta; N Chuchueva; C Gerosa; S Sionis; R A Caria; R Puxeddu
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

Review 7.  Why Do Parotid Pleomorphic Adenomas Recur? A Systematic Review of Pathological and Surgical Variables.

Authors:  Pavel Dulguerov; Jelena Todic; Marc Pusztaszeri; Naif H Alotaibi
Journal:  Front Surg       Date:  2017-05-15

8.  Review of salivary gland neoplasms.

Authors:  Victor Shing Howe To; Jimmy Yu Wai Chan; Raymond K Y Tsang; William I Wei
Journal:  ISRN Otolaryngol       Date:  2012-02-16

Review 9.  PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients.

Authors:  Shang Xie; Kan Wang; Hui Xu; Rui-Xi Hua; Tian-Zhu Li; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

10.  Partial Superficial Parotidectomy via Retroauricular Hairline Incision.

Authors:  Do-Youn Kim; Gi Cheol Park; Young-Wook Cho; Seung-Ho Choi
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-05-21       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.